Logos Global Management’s Belite Bio BLTE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLTE
DGM
Logos Global Management's BLTE Position: Q3 2026 in Review
Logos Global Management reduced its Belite Bio (BLTE) stake by 20% in Q3 2026, selling an estimated $8.12M and leaving 200,000 shares worth $34M. The position accounts for 1.83% of the portfolio, ranked #19.
Logos Global Management first reported a position in BLTE in Q2 2026 and has held it in 2 quarters since. The position peaked at $38.5M in Q2 2026. 96 funds tracked by Wall St. Rank hold BLTE as of Q3 2026.
- Logos Global Management held 200,000 shares of Belite Bio worth $34M as of Q3 2026.
- Logos Global Management sold 50,000 Belite Bio shares in Q3 2026, an estimated $8.12M.
- Belite Bio made up 1.83% of Logos Global Management's portfolio in Q3 2026, its #19 holding.
- Logos Global Management first reported a position in Belite Bio in Q2 2026 and has held it in 2 quarters since.
- Logos Global Management's Belite Bio position peaked at $38.5M in Q2 2026.
- 96 funds tracked by Wall St. Rank held Belite Bio as of Q3 2026.
Based on Logos Global Management's 13F filing for Q3 2026, filed 16 Nov 2026.